⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Exclusive: Colfax picks Goldman to sell Howden business - sources

Published 22/01/2019, 16:15
© Reuters. FILE PHOTO: The ticker symbol and logo for Goldman Sachs is displayed on a screen on the floor at the NYSE in New York
GS
-
DHR
-
ENOV
-

By Pamela Barbaglia and Arno Schuetze

LONDON/FRANKFURT (Reuters) - Colfax Corp (N:CFX) is pressing ahead with plans to sell its air and gas handling unit Howden as part of a shift to focus on the medical devices industry and has hired Goldman Sachs (NYSE:GS) to handle the process, four sources close to the matter told Reuters.

An auction process for the 165-year old Scottish company, which makes heat exchangers and gas compressors largely for oil and gas companies, is expected to kick off in the coming days, the sources said.

Colfax is hoping to fetch about 1.5 billion pounds from the sale of the business, which employs more than 5,000 people globally and has operations in 16 countries including Mexico and Canada. It employs 350 people at its main UK site in Renfrew, near Glasgow.

Howden, founded in 1854 and bought by Colfax in 2012, makes core earnings of more than 150 million pounds, two of the sources said, adding the business would mainly appeal to private equity funds due to lacklustre interest amid industry buyers.

Goldman, which declined to comment, is expected to send confidential information to potential bidders this week, one of the sources said.

Colfax was not immediately available for comment.

The sale would cement Colfax's shift from its industrial roots following the $3.15 billion purchase of medical devices maker DJO Global Inc. in November.

Colfax, which has a market value of $2.8 billion, bought DJO - its biggest ever deal - to tap growing demand for medical devices such as knee and hip implants from aging baby boomers.

At the time, it said it would explore options - including a possible sale - for Howden, which in 2017 generated 40 percent of Colfax's total revenue of $3.3 billion.

The change of direction spooked some investors, with Colfax shares tumbling 15 percent on the news.

© Reuters. FILE PHOTO: The ticker symbol and logo for Goldman Sachs is displayed on a screen on the floor at the NYSE in New York

Colfax's founders – brothers Steven and Mitchell Rales – are familiar with the medical equipment industry as they also launched Danaher Corp (N:DHR), a key player in medical devices, back in 1984. Colfax CEO Matt Trerotola worked at Danaher before joining Colfax in 2015.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.